Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Implementation of SARS-CoV-2 Wastewater Surveillance Systems in Germany-Pilot Study in the Federal State of Thuringia.

Microorganisms·2026
Same author

Automation and miniaturization of solid-phase extraction for high-throughput analysis of cyanotoxins.

Journal of chromatography. A·2025
Same author

ABPM in patients with heart failure: a long way to go.

Revista espanola de cardiologia (English ed.)·2023
Same author

The Disease Course of Hospitalized COVID-19 Patients During the Delta and Omicron Periods in Consideration of Vaccination Status.

Deutsches Arzteblatt international·2022
Same author

Characteristics and outcomes of COVID-19 patients during B.1.1.529 (Omicron) dominance compared to B.1.617.2 (Delta) in 89 German hospitals.

BMC infectious diseases·2022
Same author

Macrocytic anemia in Lesch-Nyhan disease and its variants.

Genetics in medicine : official journal of the American College of Medical Genetics·2018

Related Experiment Video

Updated: Jul 9, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

Comprehensive cardiovascular risk management--what does it mean in practice?

Leif Erhardt1, Robert Moller, Juan García Puig

  • 1Department of Cardiology, University of Lund, Malmö University Hospital, Sweden. Leif.Erhardt@med.lu.se

Vascular Health and Risk Management
|December 15, 2007
PubMed
Summary

Managing overall cardiovascular risk, not just individual factors, is key to slowing cardiovascular disease (CVD) progression. Optimal CVD management requires integrating medical and public health strategies for better prevention and treatment outcomes.

Related Experiment Videos

Last Updated: Jul 9, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

Area of Science:

  • Cardiology
  • Public Health
  • Preventive Medicine

Background:

  • Cardiovascular disease (CVD) management is suboptimal despite advancements.
  • Current strategies focus on individual risk factors, shifting towards overall and lifetime risk management.
  • Effective implementation of existing CVD knowledge and tools remains a challenge.

Purpose of the Study:

  • To outline a comprehensive approach to cardiovascular disease (CVD) management.
  • To emphasize the need for integrating medical and public health strategies.
  • To highlight the importance of understanding CVD's multifactorial nature.

Main Methods:

  • Review of current CVD management guidelines and strategies.
  • Analysis of the shift from individual risk factor treatment to overall CVD risk management.
  • Discussion of medical and public health approaches for CVD prevention.

Main Results:

  • A comprehensive approach to CVD management is essential for effective control.
  • Integrating population-based strategies alongside high-risk management can reduce the at-risk population.
  • Improvements in guidelines, risk assessment, and treatments are ongoing but insufficient alone.

Conclusions:

  • Preventing the CVD epidemic requires a combined medical and public health approach.
  • Shifting focus to overall and lifetime cardiovascular risk management is crucial.
  • Implementing population-based strategies is vital to reduce the number of individuals at risk for CVD.